Oncogenes and Tumor Progression: State of the Art

  • F. M. Van Roy
  • M. M. Mareel


Among tumors, benign and malignant ones can be discerned. The difference between both types is of the utmost importance for prognosis and therapy. Malignant tumors invade the surrounding tissues, lymph and blood vessels.


NMuMG Cell Mouse Skin Carcinogenesis Tumor Cell Autocrine Motility Factor Benign Skin Papilloma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Balmain A, Ramsden M, Bowden GT, Smith J (1984) Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 307:658–660PubMedCrossRefGoogle Scholar
  2. Barbacid M (1986) Mutagens, oncogenes and cancer. Trends Genet 2:188–192CrossRefGoogle Scholar
  3. Bar-Sagi D, Feramisco JR (1986) Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science 233:1061–1068PubMedCrossRefGoogle Scholar
  4. Bishop JM (1987) The molecular genetics of cancer. Science 235:305–311PubMedCrossRefGoogle Scholar
  5. Bondy GP, Wilson S, Chambers AF (1985) Experimental metastatic ability of H-ras-trans-formed NIH3T3 cells. Cancer Res 45:6005–6009PubMedGoogle Scholar
  6. Bos JL (1988) The ras gene family and human carcinogenesis. Mutat Res 195:255–271PubMedGoogle Scholar
  7. Bradley M, Kraynak AR, Storer RD, Gibbs JB (1986) Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes. Proc Natl Acad Sci USA 83:5277–5281PubMedCrossRefGoogle Scholar
  8. Brown K, Quintanilla M, Ramsden M, Kerr IB, Young S, Balmain A (1986) v-ras Genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis. Cell 46:447–456PubMedCrossRefGoogle Scholar
  9. Chadwick DE, Lagarde AE (1988) Coincidental acquisition of growth autonomy and metastatic potential during the malignant transformation of factor-dependent CCL39 lung fibroblasts. JNCI 80:318–325PubMedGoogle Scholar
  10. Collard JG, van Beek WP, Janssen JWG, Schijven JF (1985) Transfection by human oncogenes: Concomitant induction of tumorigenicity and tumor-associated membrane alterations. Int J Cancer 35:207–214PubMedCrossRefGoogle Scholar
  11. Collard JG, Schijven JF, Roos E (1987) Invasive and metastatic potential induced by ras-transfection into mouse BW5147 T-lymphoma cells. Cancer Res 45:754–759Google Scholar
  12. Coopman P, Van Roy F, Dragonetti C, Gao J, Fiers W, Meneguzzi G, Mareel M (1989) Tumorigenicity, invasiveness and metastatic capability of FR3T3 rat cells before and after transfection with bovine papilloma virus type 1 DNA. Clin Expl Metastasis 7:69–84CrossRefGoogle Scholar
  13. Denhardt DT, Greenberg AH, Egan SE, Hamilton RT, Wright JA (1987) Cysteine pro-teinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts. Oncogene 2:55–59PubMedGoogle Scholar
  14. Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS (1987) B1–6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236:582–585PubMedCrossRefGoogle Scholar
  15. Egan SE, McClarthy GA, Jarolim L, Wright JA, Spiro I, Hager G, Greenberg AH (1987a) Expression of H-ras correlates with metastatic potential: Evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells. Mol Cell Biol 7:830–837PubMedGoogle Scholar
  16. Egan SE, Wright JA, Jarolim L, Yanagihara K, Bassin RH, Greenberg AH (1987b) Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 238:202–205PubMedCrossRefGoogle Scholar
  17. Gao J, Van Roy F, Messiaen L, Cosaert J, Liebaut G, Coopman P, Fiers W, Mareel M (1987) Pathology of tumours produced in syngeneic Fischer rats by fibroblast-like cells before and after transfection with oncogenes. Pathol Res Pract 182:48–57PubMedCrossRefGoogle Scholar
  18. Garbisa S, Pozzatti R, Muschel RJ, Saffiotti U, Ballin M, Goldfarb RH, Khoury G, Liotta LA (1987) Secretion of type IV collagenolytic protease and metastatic phenotype: Induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-Ela. Cancer Res 47:1523–1528PubMedGoogle Scholar
  19. Garcia I, Sordat B, Rauccio-Farinon E, Dunand M, Kraehenbuhl J-P, Diggelmann H (1986) Establishment of two rabbit mammary epithelial cell lines with distinct oncogenic potential and differentiated phenotype after microinjection of transforming genes. Mol Cell Biol 6:1974–1982PubMedGoogle Scholar
  20. Glenn J, McDonald D, Horetsky RL, Sexton FM (1988) Metastatic phenotype in murine cells transfected with human DNA. J Surg Res 44:382–390PubMedCrossRefGoogle Scholar
  21. Greig RG, Koestler TP, Trainer DL, Corwin SP, Miles L, Kline T, Sweet R, Yokoyama S, Poste G (1985) Tumorigenic and metastatic properties of “normal” and ras-transfected NIH/3T3 cells. Proc Natl Acad Sci USA 82:3698–3701PubMedCrossRefGoogle Scholar
  22. Hancock JF, Marshall CJ, McKay IA, Gardner S, Houslay MD, Hall A, Wakelam MJO (1988) Mutant but not normal p21 ras elevates inositol phospholipid breakdown in two different cell systems. Oncogene 3:187–193PubMedGoogle Scholar
  23. Harper JR, Reynolds SH, Greenhalgh DA, Strickland JE, Lacal JC, Yuspa SH (1987) Analysis of the rasH oncogene and its p21 product in chemically induced skin tumors and tumor-derived cell lines. Carcinogenesis 8:1821–1825PubMedCrossRefGoogle Scholar
  24. Hill SA, Wilson S, Chambers AF (1988) Clonal heterogeneity, experimental metastatic ability, and p21 expression in H-ras-transformed NIH 3T3 cells. JNCI 80:484–490PubMedGoogle Scholar
  25. Hynes NE, Jaggi R, Kozma SC, Ball R, Muellener D. Wetherall NT, Davis BW, Groner B (1985) New acceptor cell for transfected genomic DNA: Oncogene transfer into a mouse mammary epithelial cell line. Mol Cell Biol 5:268–272PubMedGoogle Scholar
  26. Kozlowski JM, McEwan R, Keer H, Sensibar J, Sherwood III ER, Lee C, Grayhack JT, Albini A, Martin GR (1988) Prostate cancer and the invasive phenotype: Application of new in vivo and in vitro approaches. In: Nicolson GL, Fidler IJ (eds) Tumor progression and metastasis. Liss, New York, pp 189–231. (UCLA symposia on molecular and cellular biology, new series 78)Google Scholar
  27. Kris RM, Avivi A, Bar-Eli M, Alon Y, Carmi P, Schlessinger J, Raz A (1985) Expression of Ki-ras oncogene in tumor cell variants exhibiting different metastatic capabilities. Int J Cancer 35:227–230PubMedCrossRefGoogle Scholar
  28. Kushtai G, Barzilay J, .Feldman M, Eisenbach L (1988) The c-fos proto-oncogene in murine 3LL carcinoma clones controls the expression of MHC genes. Oncogene 2:119–127PubMedGoogle Scholar
  29. Leon J, Kamino H, Steinberg JJ, Pellicer A (1988) H-ras activation in benign and self-regressing skin tumors (keratoacanthomas) in both humans and an animal model system. Mol Cell Biol 8:786–793PubMedGoogle Scholar
  30. Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang PK, Schiffman E (1986) Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83:3302–3306PubMedCrossRefGoogle Scholar
  31. Mareel MM, Van Roy FM (1986) Are oncogenes involved in invasion and metastasis? Anticancer Res 6:419–436PubMedGoogle Scholar
  32. Mareel M, Coopman P, Dragonetti C, Fiers W, Gao J, Messiaen L, Van Roy F (1988a) Spontaneous and oncogene-mediated acquisition of the invasive phenotype by cells in culture. In: Nicolson GL, Fidler IJ (eds) Tumor progression and metastasis. Liss, New York, pp 179–188 (UCLA symposia on molecular and cellular biology, new series 78)Google Scholar
  33. Mareel M, Van Roy F, Bruyneel E, Bolscher J, Schallier D, De Mets M (1988b) Molecular biology of minimal invasion. Recent Results Cancer Res 106:14–20PubMedGoogle Scholar
  34. Masters SB, Bourne HR (1986) Role of G proteins in transmembrane signaling: Possible functional homology with the ras proteins. In: Kahn P, Graf T (eds) Oncogenes and growth control. Springer, Berlin Heidelberg New York, pp 184–191CrossRefGoogle Scholar
  35. McMenamin MM, Hayle AJ, Darling DL, Whittaker PA, Tutty B, Clarke PJ, Tarin D (1988) Genetic basis of metastases. In: Prodi G, Liotta LA, Lollini P-L, Garbisa S, Gorini S, Hellman K (eds) Cancer metastasis. Biological and clinical aspects. Plenum, New York, pp 269–279Google Scholar
  36. Muschel RJ, Williams JE, Lowy DR, Liotta LA (1985) Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell. Am J Pathol 121:1–8PubMedGoogle Scholar
  37. Muschel RJ, Nakahara K, Chu E, Pozzatti R, Liotta LA (1986) Karyotypic analysis of diploid or near diploid metastatic Harvey ras transformed rat embryo fibroblasts. Cancer Res 46:4104–4108PubMedGoogle Scholar
  38. Nicolson GL, Dulski KM, Trosko JE (1988) Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells. Proc Natl Acad Sci USA 85:473–476PubMedCrossRefGoogle Scholar
  39. Owen RD, Ostrowski MC (1987) Rapid and selective alterations in the expression of cellular genes accompany conditional transcription of Ha-v-ras in NIH 3T3 cells. Mol Cell Biol 7:2512–2520PubMedGoogle Scholar
  40. Owens RB, Smith HS, Hackett AJ (1974) Epithelial cell cultures from normal glandular tissue of mice. JNCI 53:261–269PubMedGoogle Scholar
  41. Pohl J, Goldfinger N, Radler-Pohl A, Rotter V, Schirrmacher V (1988) p53 Increases experimental metastatic capacity of murine carcinoma cells. Mol Cell Biol 8:2078–2081PubMedGoogle Scholar
  42. Pozzatti R, Muschel R, Williams J, Padmanabhan R, Howard B, Liotta L, Khoury G (1986) Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. Science 232:223–227PubMedCrossRefGoogle Scholar
  43. Pozzatti R, McCormick M, Thompson MA, Khoury G (1988) The Ela gene of adenovirus type 2 reduces the metastatic potential of ras-transformed rat embryo cells. Mol Cell Biol 8:2984–2988PubMedGoogle Scholar
  44. Quintanilla M, Brown K, Ramsden M, Balmain A (1986) Carcinogenic-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322:78–80PubMedCrossRefGoogle Scholar
  45. Radler-Pohl A, Pohl J, Schirrmacher V (1988) Selective enhancement of metastatic capacity in mouse bladder carcinoma cells after transfection with DNA from liver metastases of human colon carcinoma. Int J Cancer 41:840–846PubMedCrossRefGoogle Scholar
  46. Reynolds SH, Stowers SJ, Maronpot RR, Anderson MW, Aaronson SA (1986) Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse. Proc Natl Acad Sci USA 83:33–37PubMedCrossRefGoogle Scholar
  47. Reynolds VL, DiPietro M, Lebovitz RM, Lieberman MW (1987) Inherent tumorigenic and metastatic properties of Rat-1 and Rat-2 cells. Cancer Res 47:6384-6387PubMedGoogle Scholar
  48. Rhim JS, Jay G, Arnstein P, Price FM, Sanford KK, Aaronson SA (1985) Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science 227:1250–1252PubMedCrossRefGoogle Scholar
  49. Sadowski I, Pawson T, Lagarde A (1988) v-fps Protein-tyrosine kinase coordinately enhances the malignancy and growth factor responsiveness of pre-neoplastic lung fibroblasts. Oncogene 2:241–247PubMedGoogle Scholar
  50. Santer UV, Gilbert F, Glick MC (1984) Change in glycosylation of membrane glycoproteins after transfection of NIH 3T3 with human tumor DNA. Cancer Res 44:3730–3735PubMedGoogle Scholar
  51. Spandidos DA, Anderson MLM (1987) A study of mechanisms of carcinogenesis by gene transfer of oncogenes into mammalian cells. Mutat Res 185:271–291PubMedGoogle Scholar
  52. Spandidos DA; Wilkie NM (1984) Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature 310:469–475PubMedCrossRefGoogle Scholar
  53. Stern DF, Roberts AB, Roche NS, Sporn MB, Weinberg RA (1986) Differential responsiveness of myc- and ras-transfected cells to growth factors: Selective stimulation of myc-transfected cells by epidermal growth factor. Mol Cell Biol 6:870–877PubMedGoogle Scholar
  54. Storer RD, Stein RB, Sina JF, DeLuca JG, Allen HL, Bradley MO (1986) Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene. Cancer Res 46:1458–1464PubMedGoogle Scholar
  55. Storer RD, Allen HL, Kraynak AR, Bradley MO (1988) Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes. Oncogene 2:141–147PubMedGoogle Scholar
  56. Thorgeirsson UP, Turpeenniemi-Hujanen T, Williams JE, Westin EH, Heilman CA, Tal-madge JE, Liotta LA (1985) NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 5:259–262PubMedGoogle Scholar
  57. Van Roy FM, Messiaen L, Liebaut G, Gao J, Dragonetti CH, Fiers WC, Mareel MM (1986) Invasiveness and metastatic capability of rat fibroblast-like cells before and after transfec-tion with immortalizing and transforming genes. Cancer Res 46:4787–4795PubMedGoogle Scholar
  58. Varani J, Fligiel SEG, Wilson B (1986) Motility of rasH oncogene transformed NIH-3T3 cells. Invasion Metastasis 6:335–346PubMedGoogle Scholar
  59. Versteeg R, Noordermeer IA, Kruse-Wolters M, Ruiter DJ, Schrier PI (1988) c-myc down-regulates class I HLA expression in human melanomas. EMBO J 7:1023–1029PubMedGoogle Scholar
  60. Vleminckx K, Van Roy F, Fiers W, Dragonetti C, De Bruyne G, Mareel M (1988) Malignancy of mesothelial and epithelial cells before and after gene transfer. Cytotechnology 1:S63Google Scholar
  61. Vousden KH, Marshall CJ (1984) Three different activated ras genes in mouse tumours; evidence for oncogene activation during progression of a mouse lymphoma. EMBO J 3:913–917PubMedGoogle Scholar
  62. Vousden KH, Eccles SA, Purvies H, Marshall CJ (1986) Enhanced spontaneous metastasis of mouse carcinoma cells transfected with an activated c-Ha-ras-1 gene. Int J Cancer 37:425–433PubMedCrossRefGoogle Scholar
  63. Waghorne C, Kerbel RS, Breitman ML (1987) Metastatic potential of SP1 mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras. Oncogene 1:149–155PubMedGoogle Scholar
  64. Weinberg RA (1985) The action of oncogenes in the cytoplasm and nucleus. Science 230:770–776PubMedCrossRefGoogle Scholar
  65. Wiseman RW, Stowers SJ, Miller EC, Anderson MW, Miller JA (1986) Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3F1 mouse. Proc Natl Acad Sci USA 83:5825–5829PubMedCrossRefGoogle Scholar
  66. Wolfman A, Macara IG (1987) Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts. Nature 325:359–361PubMedCrossRefGoogle Scholar
  67. Yoakum GH, Lechner JF, Gabrielson EW, Korba BE, Malan-Shibley L, Willey JC, Valerio MG et al. (1985) Transformation of human bronchial epithelial cells transfected by Harvey ras oncogene. Science 227:1174–1179PubMedCrossRefGoogle Scholar
  68. Zhan X, Goldfarb M (1986) Growth factor requirements of oncogene-transformed NIH 3T3 and BALB/c 3T3 cells cultured in defined media. Mol Cell Biol 6:3541–3544PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • F. M. Van Roy
    • 1
  • M. M. Mareel
    • 2
  1. 1.Laboratory of Molecular BiologyState University of GhentGhentBelgium
  2. 2.Laboratory of Experimental CancerologyState University of GhentGhentBelgium

Personalised recommendations